These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26105207)

  • 1. Src family kinases differentially influence glioma growth and motility.
    Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
    Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.
    Kim YJ; Hong S; Sung M; Park MJ; Jung K; Noh KW; Oh DY; Lee MS; Oh E; Shin YK; Choi YL
    Oncotarget; 2016 Dec; 7(50):82876-82888. PubMed ID: 27756880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.
    Stettner MR; Wang W; Nabors LB; Bharara S; Flynn DC; Grammer JR; Gillespie GY; Gladson CL
    Cancer Res; 2005 Jul; 65(13):5535-43. PubMed ID: 15994925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.
    Park SI; Zhang J; Phillips KA; Araujo JC; Najjar AM; Volgin AY; Gelovani JG; Kim SJ; Wang Z; Gallick GE
    Cancer Res; 2008 May; 68(9):3323-33. PubMed ID: 18451159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
    Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS
    Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.
    Wheeler SE; Morariu EM; Bednash JS; Otte CG; Seethala RR; Chiosea SI; Grandis JR
    Clin Cancer Res; 2012 May; 18(10):2850-60. PubMed ID: 22490227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
    Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
    Je DW; O YM; Ji YG; Cho Y; Lee DH
    Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Src family kinases in growth and migration of glioma stem cells.
    Han X; Zhang W; Yang X; Wheeler CG; Langford CP; Wu L; Filippova N; Friedman GK; Ding Q; Fathallah-Shaykh HM; Gillespie GY; Nabors LB
    Int J Oncol; 2014 Jul; 45(1):302-10. PubMed ID: 24819299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
    Tabariès S; Annis MG; Hsu BE; Tam CE; Savage P; Park M; Siegel PM
    Oncotarget; 2015 Apr; 6(11):9476-87. PubMed ID: 25823815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients.
    Roseweir AK; Qayyum T; Lim Z; Hammond R; MacDonald AI; Fraser S; Oades GM; Aitchison M; Jones RJ; Edwards J
    BMC Cancer; 2016 Mar; 16():229. PubMed ID: 26984511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy.
    Liu WM; Huang P; Kar N; Burgett M; Muller-Greven G; Nowacki AS; Distelhorst CW; Lathia JD; Rich JN; Kappes JC; Gladson CL
    PLoS One; 2013; 8(8):e70804. PubMed ID: 23936469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases.
    Mohammed S; Shamseddine AA; Newcomb B; Chavez RS; Panzner TD; Lee AH; Canals D; Okeoma CM; Clarke CJ; Hannun YA
    Breast Cancer Res; 2021 Jul; 23(1):76. PubMed ID: 34315513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation.
    Dhruv HD; Whitsett TG; Jameson NM; Patel F; Winkles JA; Berens ME; Tran NL
    Carcinogenesis; 2014 Jan; 35(1):218-26. PubMed ID: 23975833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the prognosis for patients with glioblastoma: the rationale for targeting Src.
    de Groot J; Milano V
    J Neurooncol; 2009 Nov; 95(2):151-163. PubMed ID: 19436954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis.
    Feng H; Hu B; Jarzynka MJ; Li Y; Keezer S; Johns TG; Tang CK; Hamilton RL; Vuori K; Nishikawa R; Sarkaria JN; Fenton T; Cheng T; Furnari FB; Cavenee WK; Cheng SY
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3018-23. PubMed ID: 22323579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells.
    Buettner R; Mesa T; Vultur A; Lee F; Jove R
    Mol Cancer Res; 2008 Nov; 6(11):1766-74. PubMed ID: 19010823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasion.
    Huveldt D; Lewis-Tuffin LJ; Carlson BL; Schroeder MA; Rodriguez F; Giannini C; Galanis E; Sarkaria JN; Anastasiadis PZ
    PLoS One; 2013; 8(2):e56505. PubMed ID: 23457577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.
    Chan CM; Jing X; Pike LA; Zhou Q; Lim DJ; Sams SB; Lund GS; Sharma V; Haugen BR; Schweppe RE
    Clin Cancer Res; 2012 Jul; 18(13):3580-91. PubMed ID: 22586301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.